Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $42.00 Average PT from Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, seven have given a buy rating and […]
19 Sep 07:28 · The Markets Daily